Elite Pharmaceuticals Inc (ELTP): For example, he "hoped" we didn't have t...

Send PM Follow Ignore

Re: Dante Fantasia post# 171955

Tuesday, 11/10/2015 7:47:31 PM

Tuesday, November 10, 2015 7:47:31 PM

For example, he "hoped" we didn't have to do efficacy, but always said defer to the FDA,

Could have a little to do with he said "no one can stop us" not even the FDA.

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 08:47:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM

InvestorsHub NewsWire

Only $200 per official company press release!